Related Experiment Video
Updated: Mar 26, 2026

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
Published on: November 4, 2016
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity
Ming Sheng Lim1, Karla Lemmert2, Anoop Enjeti1
1Department of Haematology, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive cancer. This case highlights its classic presentation, treatment strategies, and diagnostic tools for better patient outcomes.
Area of Science:
- Hematology
- Oncology
- Dermatology
Background:
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an uncommon and aggressive hematologic malignancy.
- It predominantly affects elderly individuals and is characterized by frequent skin and bone marrow involvement.
- BPDCN carries a poor prognosis, necessitating effective diagnostic and therapeutic approaches.
Observation:
- This report details a specific case of BPDCN exhibiting a classic clinical presentation.
- The case underscores the importance of comprehensive diagnostic evaluations.
- Monitoring treatment response through various investigative tools is crucial.
Findings:
- The study discusses current and potential treatment modalities for BPDCN.
- It evaluates the utility of diagnostic tools in initial BPDCN identification.
- The effectiveness of investigations in assessing treatment response is analyzed.
Implications:
- Accurate diagnosis and staging are critical for effective BPDCN management.
- Understanding the value of different investigation tools can optimize patient care.
- This case contributes to the knowledge base for treating this rare hematologic malignancy.
More Related Videos
13:34Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
Published on: March 17, 2014
06:12Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro
Published on: March 7, 2022